Linda de Young, PhD

Senior Vice President Development

Dr. de Young served as the Principal of IND Enabling Consulting, providing project leadership and strategic drug development services for early stage companies. Linda worked with Domain Associates and Sofinnova Ventures portfolio companies, as well as privately funded companies in a broad range of therapeutic areas including small molecule, protein, antisense and cell-based therapies. Previously, Linda was Vice President of Development at Threshold Pharmaceuticals. Prior to Threshold Pharmaceuticals she was Vice President of Development at Angiogenix before which she held scientific positions at AeroGen and Genentech. She received her Ph.D. in Pharmaceutical Chemistry from University of California, San Francisco.

« Go Back